OPEN END TURBO OHNE STOP-LOSS - INNOCAN PHARMA

OPEN END TURBO OHNE STOP-LOSS - INNOCAN PHARMA Share Price

DE000LX21J38

Market Closed - Börse Stuttgart 11:40:10 07/06/2024 am IST
0.1 ^EUR	0.00%

Current month	-9.09%
1 month	-16.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INNOCAN PHARMA CORPORATION

Chart OPEN END TURBO OHNE STOP-LOSS - INNOCAN PHARMA

Quotes 5-day view

Date	Price	Change
07/24/07	0.1	0.00%
06/24/06	0.1	0.00%
05/24/05	0.1	-9.09%
04/24/04	0.11	0.00%
03/24/03	0.11	0.00%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 11:40 am IST

More quotes

Static data

Product type	Knock-Out without Stop Loss
Buy / Sell	CALL
Underlying	INNOCAN PHARMA CORPORATION
Issuer	Lang & Schwarz
WKN	LX21J3
ISIN	DE000LX21J38
Date issued	05/04/2023
Strike	0.1 €
Maturity	Unlimited
Parity	1 : 1
Emission price	0.09 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.23 €
Lowest since issue	0.037 €

Company Profile

Innocan Pharma Corporation is an Israel-based pharmaceutical company active in the medical cannabis industry. It operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research and Development of Non-pharmaceutical products for third parties and Research and Development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales. The Company is developing an OTC topical treatments product line and new platform to facilitate the targeted controlled administration of cannabinoids via injection.

Sector

More about the company